NIRBA is a pioneering national program dedicated to advancing RNA biology research. Established with support from the National Research Foundation (NRF) under the Prime Minister’s Office, Singapore, we unite experts across multiple disciplines to address critical challenges in RNA science and its applications. In collaboration with Singapore’s leading research institutions — the National University of Singapore (NUS), Nanyang Technological University (NTU), and the Agency for Science, Technology and Research (A*STAR) — NIRBA underscores Singapore’s commitment to cutting-edge research with tangible benefits for human health and the bioeconomy. Our goal is to position Singapore as a global leader in RNA biology research.
The establishment of NIRBA comes at a transformative moment in RNA biology, a field that has rapidly emerged as one of the most dynamic and impactful in modern science. From revolutionising vaccine technology during the COVID-19 pandemic to enabling novel treatments for previously untreatable diseases, RNA-based innovations are reshaping medicine and biotechnology. Beyond vaccines, RNA biology holds immense potential for breakthroughs in disease treatment, personalised medicine, food security, and sustainable biotechnology. However, realising these advances depends on a deep and fundamental understanding of RNA biology. NIRBA is committed to bridging scientific gaps and leveraging Singapore’s strengths — particularly its unique focus on the genetic diversity of Asian populations — to enhance healthcare, improve lives, and strengthen economic resilience.
At the heart of NIRBA is a commitment to world-class foundational RNA research. Our initiative is structured around dedicated Innovation Clusters, each addressing a key challenge in RNA biology:
Through these clusters, NIRBA drives both innovation and translational research, supporting key national priorities such as PRECISE (precision medicine), NATi (RNA therapeutics and the RNA foundry), and PrepVax (pandemic preparedness). These efforts will ensure Singapore remains at the forefront of RNA science and its applications.
NIRBA is more than a research initiative — it is a collaborative platform that brings together leading minds from academia, healthcare, and industry, both locally and globally. By fostering strategic partnerships, we are building a dynamic ecosystem where researchers, clinicians, and innovators can work together to push the boundaries of RNA science. Our research is not only foundational but also translational, ensuring tangible benefits for society.
As we embark on this transformative journey, I invite you to explore our website to learn more about our mission, research focus, and opportunities for collaboration. Together, we can pioneer solutions that redefine health, biotechnology, and sustainability for future generations.
